PharVision Advisers’s Trupanion TRUP Stock Holding History

PharVision Advisers’s Portfolio TRUP Stock Details TRUP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-6,910	Closed	-$258K	–	605
2025 Q4	$258K	Buy	+6,910	New	+$271K	0.13%	374

Other funds holding TRUP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Aflac Inc Columbus, Georgia $92.6M AUM 53.83% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

PCH

Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

GLCM

Greenlea Lane Capital Management Weston, Connecticut $364M AUM 5.09% 1-Year Est. Return

PharVision Advisers's TRUP Position: Q1 2026 in Review

PharVision Advisers sold out of Trupanion (TRUP) in Q1 2026, closing a stake of 6,910 shares — an estimated $258K sold.

PharVision Advisers first reported a position in TRUP in Q4 2025 and held it in 1 quarter. The position peaked at $258K in Q4 2025. 204 funds tracked by Wall St. Rank hold TRUP as of Q1 2026.

PharVision Advisers reported no remaining Trupanion position as of Q1 2026 after selling out during the quarter.
PharVision Advisers sold 6,910 Trupanion shares in Q1 2026, an estimated $258K.
PharVision Advisers first reported a position in Trupanion in Q4 2025 and held it in 1 quarter.
PharVision Advisers's Trupanion position peaked at $258K in Q4 2025.
204 funds tracked by Wall St. Rank held Trupanion as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.